Africa: MSF Prepares To Launch An Innovative Long-Acting HIV Prevention Program In Several African Countries
In 2022, the WHO recommended the innovative long-acting injectable version of HIV Pre-exposure Prophylaxis (PrEP), Cabotegravir (CAB-LA), as part of a comprehensive approach to HIV prevention. CAB-LA has been described as a potential game-changer in the fight against HIV, a disease that has affected many people. Nearly 40 million people were living with HIV at the end of 2023, […]